| Year |
Citation |
Score |
| 2023 |
Byrnes SJ, Busman-Sahay K, Angelovich TA, Younger S, Taylor-Brill S, Nekorchuk M, Bondoc S, Dannay R, Terry M, Cochrane CR, Jenkins TA, Roche M, Deleage C, Bosinger SE, Paiardini M, et al. Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques. Plos Pathogens. 19: e1011290. PMID 36989320 DOI: 10.1371/journal.ppat.1011290 |
0.401 |
|
| 2022 |
Jiang S, Chan CN, Rovira-Clavé X, Chen H, Bai Y, Zhu B, McCaffrey E, Greenwald NF, Liu C, Barlow GL, Weirather JL, Oliveria JP, Nakayama T, Lee IT, Matter MS, ... ... Nekorchuk M, et al. Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironments. Immunity. PMID 35447093 DOI: 10.1016/j.immuni.2022.03.020 |
0.387 |
|
| 2022 |
Busman-Sahay K, Nekorchuk MD, Starke CE, Chan CN, Estes JD. In Situ Multiplexing to Identify, Quantify, and Phenotype the HIV-1/SIV Reservoir Within Lymphoid Tissue. Methods in Molecular Biology (Clifton, N.J.). 2407: 277-290. PMID 34985671 DOI: 10.1007/978-1-0716-1871-4_19 |
0.665 |
|
| 2021 |
Busman-Sahay K, Starke CE, Nekorchuk MD, Estes JD. Eliminating HIV reservoirs for a cure: the issue is in the tissue. Current Opinion in Hiv and Aids. 16: 200-208. PMID 34039843 DOI: 10.1097/COH.0000000000000688 |
0.631 |
|
| 2021 |
Gramatica A, Schwarzer R, Brantley W, Varco-Merth B, Sperber HS, Hull PA, Montano M, Migueles SA, Rosenthal D, Hogan LE, Johnson JR, Packard TA, Grimmett ZW, Herzig E, Besnard E, ... Nekorchuk M, et al. Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity . Journal of Virology. PMID 33536176 DOI: 10.1128/JVI.02393-20 |
0.479 |
|
| 2020 |
Harper J, Gordon S, Chan CN, Wang H, Lindemuth E, Galardi C, Falcinelli SD, Raines SLM, Read JL, Nguyen K, McGary CS, Nekorchuk M, Busman-Sahay K, Schawalder J, King C, et al. CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption. Nature Medicine. 26: 519-528. PMID 32284611 DOI: 10.1038/S41591-020-0782-Y |
0.346 |
|
| 2014 |
Sharifi HJ, Furuya AK, Jellinger RM, Nekorchuk MD, de Noronha CM. Cullin4A and cullin4B are interchangeable for HIV Vpr and Vpx action through the CRL4 ubiquitin ligase complex. Journal of Virology. 88: 6944-58. PMID 24719410 DOI: 10.1128/Jvi.00241-14 |
0.771 |
|
| 2013 |
Nekorchuk MD, Sharifi HJ, Furuya AK, Jellinger R, de Noronha CM. HIV relies on neddylation for ubiquitin ligase-mediated functions. Retrovirology. 10: 138. PMID 24245672 DOI: 10.1186/1742-4690-10-138 |
0.767 |
|
| 2013 |
Casey Klockow L, Sharifi HJ, Wen X, Flagg M, Furuya AK, Nekorchuk M, de Noronha CM. The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection. Virology. 444: 191-202. PMID 23849790 DOI: 10.1016/J.Virol.2013.06.010 |
0.69 |
|
| 2012 |
Wen X, Casey Klockow L, Nekorchuk M, Sharifi HJ, de Noronha CM. The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover. Plos One. 7: e30939. PMID 22292079 DOI: 10.1371/Journal.Pone.0030939 |
0.661 |
|
| 2010 |
Porter KA, Kelley LN, Nekorchuk MD, Jones JH, Hahn AB, de Noronha CM, Harton JA, Duus KM. CIITA enhances HIV-1 attachment to CD4+ T cells leading to enhanced infection and cell depletion. Journal of Immunology (Baltimore, Md. : 1950). 185: 6480-8. PMID 21041720 DOI: 10.4049/Jimmunol.1000830 |
0.699 |
|
| Show low-probability matches. |